Vamsee Veeramachineni is a Post-Doctoral Fellow working in the Laboratory of Bacterial Polysaccharides at CBER/U.S.FDA. His research experience is in the fields of Enzymology and Glycobiology. Dr. Veeramachineni’s current research at FDA involves the study of capsular polymerization in Neisseria meningitidis serogroup A and X. Neisseria meningitidis is the leading cause of bacterial meningitis across the globe. A capsular polysaccharide that surrounds the cell wall is a major virulence factor. It protects the bacteria from a variety of host immune responses, resulting in severe infection including death. Studying the mechanism of membrane-bound glycosyl transferases provides tools to develop vaccines and next-generation antibacterial treatments. Dr. Veeramachineni received his Ph.D. in Medicinal and Pharmaceutical Chemistry from State University of New York at Buffalo (SUNY Buffalo) with a research specialization in Enzymology.